The Medical Innovation Podcast

Reinventing the Pharmacy Cabinet - Omnicell

In this episode, we speak with Jason Woosley, Chief Product Officer at Omnicell, about bringing Silicon Valley product thinking to pharmacy automation. Jason shares how his background scaling Magento and the Adobe Commerce Cloud is shaping a new approach to hardware, software, and team structure at Omnicell, including a shift toward cloud-based infrastructure, agile AI-assisted teams, and a modular hardware strategy built around continuous delivery. We discuss how innovations like the Titan XT cabinet and the XR2 robot are reducing the cognitive burden on pharmacists, giving them back time to focus on direct patient care.

Reimagining Primary Care with Agentic AI - Lumeris

In this episode, we speak with Dr. David Carmouche, Chief Medical Officer at Lumeris, about using agentic AI to solve the primary care shortage. He explains how Lumeris built Tom, a 24/7 AI care team member named in honor of co-founder Tom Doerr, that handles proactive outreach, symptom triage, visit preparation, and clinical decision support grounded in real patient data. We discuss why safety and hallucinations have not been the obstacle many expected, how physicians are responding to AI-generated care recommendations, and why the biggest barrier to the future of primary care is not technology but the outdated fee-for-service payment model.

Listening Deeper: The AI Stethoscope Reimagined - Lapsi Health

In this episode, we speak with Dr. Jhonatan Bringas Dimitriades, co-founder and CEO of Lapsi Health, about Keikku, an FDA-cleared device that merges digital auscultation, ambient AI scribing, and voice biomarker analysis into a single clinical platform. Jhonatan explains how Lapsi Health is rethinking the stethoscope not as a niche device, but as the hardware foundation for a comprehensive healthcare AI ecosystem. We discuss the challenges of building medical hardware on a lean budget, navigating FDA Class II clearance and ISO certification, and conducting clinical trials in pediatric cardiology in Peru, and why the future of clinical AI must go beyond documentation to truly capture the full value of a patient consultation.

From Scribe to AI Care Partner - Heidi

In this episode, we speak with Dr. Tom Kelly, CEO and founder of Heidi, about the platform's evolution from a free AI scribe into a multi-product clinical AI suite now supporting nearly 2.5 million visits per week across 116 countries. Tom explains how Heidi's two newest products, Evidence and Comms, give clinicians agentic tools to query medical literature, conduct surgical audits, and engage patients across phone, text, and web with full visit context. We discuss why scribing reliability is harder than it looks, how Heidi is navigating medical device regulation in the UK and EU through their Automedica acquisition, and why Tom believes the future of clinical AI is a single platform, not a collection of disconnected point solutions.

Diagnosing the Future of Transplant Medicine - Thermo Fisher

In this episode, we speak with Tina Liedtky, Global President of Transplant Diagnostics at Thermo Fisher Scientific, about how cutting-edge diagnostics and emerging AI are reshaping organ transplantation. Tina explains how HLA compatibility testing underpins successful transplant outcomes and how innovations like the non-invasive CXCL10 urinary biomarker are expanding access to post-transplant monitoring for patients far from clinical centers. We also explore her vision for AI's role in improving donor-recipient matching for highly sensitized patients, personalizing immunosuppressive regimens, and the strategic importance of partnerships for early-stage companies navigating this specialized and highly regulated field.